Introduction: The Practice of Pharmacotherapy

  • Stephen C. Schoonover
  • Alan J. Gelenberg


Experimentation with drugs that alter mood, thinking, or perception represents a timeless human enterprise. Although largely aimed at the relief of suffering, the utilization of various pharmacological agents also reflects different cultural, religious, and political ideologies. Frequently, implementing effective pharmacological treatments depends more on social issues, economic considerations, and serendipity than on clinical factors. A historical account of the discovery and introduction of psychoactive drugs in the United States highlights these patterns.


Temporal Lobe Epilepsy Psychoactive Drug Drug Trial Lithium Salt Bipolar Affective Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sen G., Bose K. C.: Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Indian Med World 2:194–201, 1931.Google Scholar
  2. 2.
    Laborit H., Huguenard P., Alluaume R.: Un nouveau stabilisateur vegetatif, le 4560 RP. Presse Med 60:206–208, 1952.PubMedGoogle Scholar
  3. 3.
    Lehmann H. E., Hunrahan G. E.: Chlorpromazine, a new inhibiting agent for psychomotor excitement and manic states. Arch Neurol Psychiatry 71:227–237, 1954.CrossRefGoogle Scholar
  4. 4.
    Cade J. F. J.: Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352. 1949.PubMedGoogle Scholar
  5. 5.
    Sternback L. H., Randall L. O., Gustafson, S. R.: 1,4-Benzodiazepines: Chlordiazepoxide and related compounds, in Gordon M. (ed): Psychopharmacological Agents. New York, Academic Press, 1964, vol 1, 137–224.Google Scholar
  6. 6.
    Kuhn R.: The treatment of depressive states with G22355 (imipramine hydrochloride). Am J Psychiatry 115:459–464, 1958.PubMedGoogle Scholar
  7. 7.
    Group for the Advancement of Psychiatry: Pharmacotherapy and Psychotherapy: Paradoxes, Problems and Progress, report 93. New York, Group for the Advancement of Psychiatry, 1975, vol 9.Google Scholar
  8. 8.
    Weissman M. M.: The psychological treatment of depression: Evidence for the efficacy of psychotherapy done in comparison with, and in combination with, pharmacotherapy. Arch Gen Psychiatry 36:1261–1269, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    Beck A. T., Rush A. J., Shaw B. F., et al: Cognitive Therapy of Depression. New York, Guilford Press, 1979.Google Scholar
  10. 10.
    Gelenberg A. J.: New perceptions on the use of tricyclic antidepressants. J Clin Psychiatry 50:7(Suppl):3–10, 1989.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Stephen C. Schoonover
    • 1
  • Alan J. Gelenberg
    • 2
  1. 1.Newton CentreSchoonover AssociatesUSA
  2. 2.Department of PsychiatryUniversity of Arizona Health Sciences CenterTucsonUSA

Personalised recommendations